These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Efficacy of Ebola Glycoprotein-Specific Equine Polyclonal Antibody Product Against Lethal Ebola Virus Infection in Guinea Pigs. Chan M; Holtsberg FW; Vu H; Howell KA; Leung A; Van der Hart E; Walz PH; Aman MJ; Kodihalli S; Kobasa D J Infect Dis; 2018 Nov; 218(suppl_5):S603-S611. PubMed ID: 29955852 [TBL] [Abstract][Full Text] [Related]
12. Development and Characterization of a Guinea Pig-Adapted Sudan Virus. Wong G; He S; Wei H; Kroeker A; Audet J; Leung A; Cutts T; Graham J; Kobasa D; Embury-Hyatt C; Kobinger GP; Qiu X J Virol; 2016 Jan; 90(1):392-9. PubMed ID: 26491156 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of Ebola Virus Countermeasures in Guinea Pigs. Marzi A Methods Mol Biol; 2017; 1628():283-291. PubMed ID: 28573629 [TBL] [Abstract][Full Text] [Related]
14. N-Butyldeoxynojirimycin is a broadly effective anti-HIV therapy significantly enhanced by targeted liposome delivery. Pollock S; Dwek RA; Burton DR; Zitzmann N AIDS; 2008 Oct; 22(15):1961-9. PubMed ID: 18753929 [TBL] [Abstract][Full Text] [Related]
15. The combination of interferon alpha-2b and n-butyl deoxynojirimycin has a greater than additive antiviral effect upon production of infectious bovine viral diarrhea virus (BVDV) in vitro: implications for hepatitis C virus (HCV) therapy. Ouzounov S; Mehta A; Dwek RA; Block TM; Jordan R Antiviral Res; 2002 Sep; 55(3):425-35. PubMed ID: 12206880 [TBL] [Abstract][Full Text] [Related]
16. Postexposure protection of guinea pigs against a lethal ebola virus challenge is conferred by RNA interference. Geisbert TW; Hensley LE; Kagan E; Yu EZ; Geisbert JB; Daddario-DiCaprio K; Fritz EA; Jahrling PB; McClintock K; Phelps JR; Lee AC; Judge A; Jeffs LB; MacLachlan I J Infect Dis; 2006 Jun; 193(12):1650-7. PubMed ID: 16703508 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of the Activity of Lamivudine and Zidovudine against Ebola Virus. Cong Y; Dyall J; Hart BJ; DeWald LE; Johnson JC; Postnikova E; Zhou H; Gross R; Rojas O; Alexander I; Josleyn N; Zhang T; Michelotti J; Janosko K; Glass PJ; Flint M; McMullan LK; Spiropoulou CF; Mierzwa T; Guha R; Shinn P; Michael S; Klumpp-Thomas C; McKnight C; Thomas C; Eakin AE; O'Loughlin KG; Green CE; Catz P; Mirsalis JC; Honko AN; Olinger GG; Bennett RS; Holbrook MR; Hensley LE; Jahrling PB PLoS One; 2016; 11(11):e0166318. PubMed ID: 27902714 [TBL] [Abstract][Full Text] [Related]
18. Ebolavirus Glycoprotein Fc Fusion Protein Protects Guinea Pigs against Lethal Challenge. Konduru K; Shurtleff AC; Bradfute SB; Nakamura S; Bavari S; Kaplan G PLoS One; 2016; 11(9):e0162446. PubMed ID: 27622456 [TBL] [Abstract][Full Text] [Related]
19. Antiviral effects of deoxynojirimycin (DNJ)-based iminosugars in dengue virus-infected primary dendritic cells. Perera N; Brun J; Alonzi DS; Tyrrell BE; Miller JL; Zitzmann N Antiviral Res; 2022 Mar; 199():105269. PubMed ID: 35227758 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of glycogen breakdown by imino sugars in vitro and in vivo. Andersson U; Reinkensmeier G; Butters TD; Dwek RA; Platt FM Biochem Pharmacol; 2004 Feb; 67(4):697-705. PubMed ID: 14757169 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]